SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* ANDERSON KERRII B (Last) (First) (Middle) 531 SOUTH SPRING STREET (Street) BURLINGTON NC 27215 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol LABORATORY CORP OF AMERICA HOLDINGS [ LH ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 02/02/2022
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/14/2021		G	V	345	D	$0	19,967(1)	D
Common Stock	12/14/2021		G	V	345	D	$0	19,622	D
Common Stock	12/14/2021		G	V	860	D	$0	18,762	D
Common Stock	02/02/2022		M		771	A	(2)	19,533	D
Common Stock								144(3)	I	By Alexa M. Anderson Separate Trust
Common Stock								144(3)	I	By Cameron Taff Anderson Separate Trust
Common Stock								0(1)	I	By grantor retained annuity trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(2)	02/02/2022		M			771	(4)	(4)	Common Stock	771	$0	0	D

Explanation of Responses:

1. Amount reflects annuity payment of 432 shares made by the reporting person's grantor retained annuity trust to the reporting person on September 2, 2021.

2. Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

3. On September 3, 2021, the reporting person distributed of an aggregate 288 shares of Common Stock (in her capacity as trustee of the grantor retained annuity trust), to two separate trusts (144 shares of Common Stock being distributed in the form of a gift to each trust). Each of the two trusts is for the benefit of one of the reporting person's two children (who no longer share her household) and the trustee of each of the two trusts is the spouse of the reporting person. The reporting person disclaims beneficial ownership of these shares of Common Stock, and the filing of this Form 4 is not an admission that the reporting person is the beneficial owner of these Common Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

4. The Restricted Stock Units vested fully on February 2, 2022.

	/s/ Sandra D. van der Vaart, Attorney-in-Fact for Kerrii B. Anderson	02/04/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.